Predictive and pre-natal testing for Huntington Disease in Australia: results and challenges encountered during a 10-year period (1994-2003)
- 9 October 2006
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 70 (6), 480-489
- https://doi.org/10.1111/j.1399-0004.2006.00701.x
Abstract
This study summarizes 10-years' experience of predictive and pre-natal testing and pre-implantation genetic diagnosis (PGD) for Huntington disease (HD) in Australia. Results are presented from 2036 direct mutation predictive tests conducted between January 1994 and December 2003. Thirty-eight per cent of results (776/2036) were positive, 56% (1140/2036) were negative, and 6% (120/2036)) were in the mutable normal (27-35 CAG repeats) or in the reduced penetrance (36-39 CAG repeats) ranges. Ninety-four per cent (1908/2036) and 6% (128/2036) of those tested had prior genetic risks of 50% and 25%, respectively. Twenty-seven per cent (34/128) of those at 25% risk had their genetic status changed to positive, thus revealing the positive status of their at-risk parent. During this period, 63 pre-natal tests were also conducted, and 13 children were born following PGD for HD. Social workers specializing in predictive testing counselling over this 10-year period across Australia identified and summarized particularly challenging counselling issues. These included the interpretation of mutable normal and reduced penetrance range test results, potential conflicts of interest between family members regarding testing decisions, unanticipated consequences of both predictive and pre-natal testing decisions, the importance of following protocols for predictive testing to facilitate long-term adjustment to results, and the potential for genetic discrimination. The identified issues highlight the importance of the protocols for predictive testing and indicate that extension of the international guidelines published in 1994 may be timely.Keywords
This publication has 43 references indexed in Scilit:
- A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG lengthClinical Genetics, 2004
- Predictive, pre‐natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000Clinical Genetics, 2003
- Predictive genetic test decisions for Huntington's disease: context, appraisal and new moral imperativesSocial Science & Medicine, 2003
- Preimplantation genetic diagnosis for Huntington's disease with exclusion testingEuropean Journal of Human Genetics, 2002
- The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: implications for multidisciplinary counselling and for genetic educationSocial Science & Medicine, 2000
- Preimplantation diagnosis for Huntington's disease (HD): clinical application and analysis of the HD expansion in affected embryosPrenatal Diagnosis, 1998
- Laboratory Guidelines for Huntington Disease Genetic TestingAmerican Journal of Human Genetics, 1998
- Social work and genetic testing: Ethical issues encountered in predictive testing for Huntington diseaseAustralian Social Work, 1997
- Guidelines for the molecular genetics predictive test in Huntington's diseaseNeurology, 1994
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993